Clinical Characteristics Patients Pneumonia with Diabetes Mellitus at General Hospital Jakarta, Indonesia

  • Dini Permata Sari Faculty of Pharmacy, Universitas 17 Augustus 1945 Jakarta, Jakarta 14350, Indonesia
  • Ahmad Muflih Maulana Faculty of Pharmacy, Universitas 17 Augustus 1945 Jakarta, Jakarta 14350, Indonesia
  • Rangki Astiani Faculty of Pharmacy, Universitas 17 Augustus 1945 Jakarta, Jakarta 14350, Indonesia

Abstract

Background: Respiratory diseases are currently a worldwide concern, especially in Indonesia due to the increasing mortality such as pneumonia. Pneumonia is an infectious disease of the respiratory tract of the lower part that has inflammation of the pulmonary parenchyma, distal from the terminalis bronchioles. Risk factors for pneumonia include comorbidities. Comorbidities are often found in pneumonia patients, one of which is diabetes mellitus. The purpose of this study was to investigate the prevalence and relationship of clinical characteristics of pneumonia patients with diabetes mellitus. This study was a retrospective observational cohort study on pneumonia patients with diabetes mellitus between June 2020 and June 2021 at a general hospital in Jakarta. Univariate and multivariate analyzes were performed to examine the relationship between the clinical characteristics of patients with diabetes mellitus. The results: This study obtained 66 patients. Clinical features of pneumonia patients with diabetes mellitus were characterized by cough and shortness of breath in 52 patients (78.79%) accompanied by fever in 35 patients (53.03%). The results of the chi-square test obtained P=0.002, based on the value obtained there was a significant relationship between the clinical characteristics of pneumonia patients with diabetes mellitus. The conclusion: There was a relationship between clinical characteristics of pneumonia patients with diabetes mellitus.


Keywords: Pneumonia, Diabetes Mellitus, Comorbidities, Clinical Characteristics.

Keywords: Pneumonia, Diabetes Mellitus, Comorbidities, Clinical Characteristics

Downloads

Download data is not yet available.

Author Biographies

Dini Permata Sari, Faculty of Pharmacy, Universitas 17 Augustus 1945 Jakarta, Jakarta 14350, Indonesia

Faculty of Pharmacy, Universitas 17 Augustus 1945 Jakarta, Jakarta 14350, Indonesia

Ahmad Muflih Maulana, Faculty of Pharmacy, Universitas 17 Augustus 1945 Jakarta, Jakarta 14350, Indonesia

Faculty of Pharmacy, Universitas 17 Augustus 1945 Jakarta, Jakarta 14350, Indonesia

Rangki Astiani, Faculty of Pharmacy, Universitas 17 Augustus 1945 Jakarta, Jakarta 14350, Indonesia

Faculty of Pharmacy, Universitas 17 Augustus 1945 Jakarta, Jakarta 14350, Indonesia

References

1. Raghu G, Meyer KC. Cryptogenic organising pneumonia: Current understanding of an enigmatic lung disease. European Respiratory Review. 2021; 30(161). https://doi.org/10.1183/16000617.0094-2021
2. Kochanek KD, Sherry MA;, Murphy L, Xu J. National Vital Statistics Reports, 2015; 63(3):2011. http://www.cdc.gov/nchs/deaths.htm.
3. Brar NK, Niederman MS. Management of community-acquired pneumonia: A review and update. Ther Adv Respir Dis. 2011; 5(1):61-78. https://doi.org/10.1177/1753465810381518
4. Ewig S, Birkner N, Strauss R, et al. New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality. Thorax. 2009; 64(12):1062-1069. https://doi.org/10.1136/thx.2008.109785
5. Eccles S, Pincus C, Higgins B, et al. Diagnosis and management of community and hospital acquired pneumonia in adults: Summary of NICE guidance. The BMJ. 2014; 349. https://doi.org/10.1136/bmj.g6722
6. Sato R, Gomez Rey G, Nelson S, Pinsky B. Community-acquired pneumonia episode costs by age and risk in commercially insured US adults aged ≥50 years. Appl Health Econ Health Policy. 2013; 11(3):251-258. https://doi.org/10.1007/s40258-013-0026-0
7. Holter JC, Ueland T, Jenum PA, et al. Risk factors for long-term mortality after hospitalization for community-acquired pneumonia: a 5-year prospective follow-up study. PLoS One. 2016; 11(2). https://doi.org/10.1371/journal.pone.014874
8. Antoni T, Blasi F, Dartois N, Akova M. Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease. Thorax. 2015; 70(10):984-989. https://doi.org/10.1136/thoraxjnl-2015-206780
9. Fulop T, Witkowski JM, Pawelec G, Alan C, Larbi A. On the immunological theory of aging. In: Aging: Facts and Theories. Vol 39. S. Karger AG; 2014; 39:163-176. https://doi.org/10.1159/000358904
10. Chapman SW, Bradsher RW, Campbell GD, Pappas PG, Kauffman CA. Practice Guidelines for the Management of Patients with Blastomycosis. https://academic.oup.com/cid/article/30/4/679/421475 https://doi.org/10.1086/313750
11. Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Kaabi J al. Epidemiology of Type 2 diabetes - Global burden of disease and forecasted trends. J Epidemiol Glob Health. 2020; 10(1):107-111. https://doi.org/10.2991/jegh.k.191028.001
12. Ishiguro T, Takayanagi N, Yamaguchi S, et al. Etiology and factors contributing to the severity and mortality of community-acquired pneumonia. Internal Medicine. 2013; 52(3):317-324. https://doi.org/10.2169/internalmedicine.52.8830
13. Biscevic-Tokic J, Tokic N, Musanovic A. Pneumonia as the most common lower respiratory tract infection. Med Arch. 2013; 67(6):442-445. https://doi.org/10.5455/medarh.2013.67.442-445
14. Kautzky-Willer A, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr Rev. 2016; 37(3):278-316. https://doi.org/10.1210/er.2015-1137
15. Long B, Long D, Koyfman A. Emergency Medicine Evaluation of Community-Acquired Pneumonia: History, Examination, Imaging and Laboratory Assessment, and Risk Scores. Journal of Emergency Medicine. 2017; 53(5):642-652. https://doi.org/10.1016/j.jemermed.2017.05.035
16. Mohamed SA. Effect of lifestyle intervention on health behaviors, weight and blood glucose level among patients with diabetes mellitus. J Nurs Educ Pract. 2014; 4(12). https://doi.org/10.5430/jnep.v4n12p75
17. Ojo O, Wang XH, Ojo OO, Ibe J. The effects of substance abuse on blood glucose parameters in patients with diabetes: A systematic review and meta-analysis. Int J Environ Res Public Health. 2018; 15(12). https://doi.org/10.3390/ijerph15122691
18. Kornum JB, Thomsen RW, Riis A, Lervang HH, Schønheyder HC, Sørensen HT. Diabetes, glycemic control, and risk of hospitalization with pneumonia: A population-based case-control study. Diabetes Care. 2008; 31(8):1541-1545. https://doi.org/10.2337/dc08-0138
19. Hirata Y, Tomioka H, Sekiya R, et al. Association of hyperglycemia on admission and during hospitalization with mortality in diabetic patients admitted for pneumonia. Internal Medicine. 2013; 52(21):2431-2438. https://doi.org/10.2169/internalmedicine.52.9594
Statistics
42 Views | 4 Downloads
How to Cite
1.
Sari DP, Maulana A, Astiani R. Clinical Characteristics Patients Pneumonia with Diabetes Mellitus at General Hospital Jakarta, Indonesia. JDDT [Internet]. 15Nov.2022 [cited 9Dec.2022];12(6):1-. Available from: https://jddtonline.info/index.php/jddt/article/view/5744